AHA 2021 | CRAVE: Coffee Safety in Rhythm Disorders

On the one side, caffeine can increase arrythmias or interfere with sleeping, but on the other hand, it helps people feel more energetic and do more physical activity. 

AHA 2021 | CRAVE: Seguridad del café para los trastornos del ritmo

These data contribute to the evidence supporting the fact that people who present, or are at risk of presenting supra ventricular arrythmias or atrial fibrillation might not need to avoid coffee. 

The CRAVE study included 100 young volunteers with no prior arrythmia or heart disease who were instructed to modify caffeine intake habits in two-day blocks. 

Coffee intake did not increase atrial arrythmia, but slightly increased premature ventricular contractions. On the other hand, the day people were allowed to have coffee, they walked 1,000 more steps vs the day coffee was not allowed (p=0.001).

Coffee intake was defined as one standard cup of coffee or an expresso. 

There were no differences between having or not having coffee and the incidence of atrial arrythmia. Also, coffee consumption was associated to fewer supra ventricular tachycardia, but more premature ventricular contractions. 


Read also: AHA 2021 | PALACS: Posterior Left Pericardiotomy Improves Post-Procedural AF.


The day participants were allowed to have coffee, they slept mean 36 minutes less than abstinence day. 

Original Title: The coffee and real-time atrial and ventricular ectopy (CRAVE) trial.

Reference: presentado por Marcus GM durante las sesiones científicas del congreso de la AHA 2021.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TAVR and Anticoagulation: What Should We Do?

Transcatheter aortic valve replacement (TAVR) has consolidated as a valid strategy for certain groups of patients. However, approximately one third of those who require...

Direct Oral Anticoagulants for Ventricular Thrombus After STEMI

While the incidence of intracavitary thrombi after acute myocardial infarction (AMI) has decreased thanks to optimized primary angioplasty times, some studies report rates of...

AHA 2024 | VANISH2 Trial

Cardiac defibrillator implants (CDIs) have been shown to improve survival in patients with ischemic cardiomyopathy and ventricular tachycardia (VT). However, approximately one third of...

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Unplanned Coronary Angiography After TAVR: Incidence, Predictors, and Outcomes

The importance of assessing coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) is well recognized due to the high prevalence of...

Intravascular Lithotripsy in Calcified Coronary Lesions: Success Predictors

Coronary artery calcification (CAC) is increasingly common in patients undergoing percutaneous coronary intervention (PCI). Intravascular lithotripsy (IVL) has been established as an effective tool...

TAVR Unload: TAVR in Moderate Aortic Stenosis and Ventricular Function Deterioration

Aortic Stenosis (AS) significantly contributes to valvulo-arterial impedance in patients with heart failure and reduced ejection fraction (HFrEF), making it a relevant therapeutic target...